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The secretory tissue of the eye, the ciliary processes, contains an enzyme receptor complex,
composed of membrane proteins, the catalytic moiety of the enzyme adenylate cyclase, a guanyl
nucleotide regulatory protein (or N protein), and other features. The enzyme can be activated
by well-known neurohumoral or humoral agents, catecholamines, glycoprotein hormones pro-
duced by the hypothalamic pituitary axis, and other related compounds, including placental
gonadotropin, organic fluorides, and forskolin, a diterpene. These compounds cause the
ciliary epithelia to produce cyclic AMP at an accelerated rate. Cyclic AMP, as a second mes-
senger, causes, either directly or indirectly, a decrease in the net rate of aqueous humor inflow
that may be modulated by cofactors. Clinical syndromes fit the experimental data so that an in-
tegrated explanation can be given for the reduced intraocular pressure witnessed under certain
central nervous system and adrenergic influences. The molecular biology of this concept pro-
vides important leads for future investigations that bear directly both upon the regulation of
intraocular pressure and upon glaucoma.
INTRODUCTION
The mechanisms responsible for the regulation of intraocular pressure (IOP)
represent a significant but largely unanswered problem. There is virtually no evi-
dence in favor but there is evidence against instantaneous regulation or feedback
control of IOP [1]. There are considerable data, however, suggesting that humoral
or neurohumoral pathways can influence the steady-state level of IOP by altering
the rate of aqueous inflow. The introduction of beta blockers for the treatment of
glaucoma prompted a renewed and intense interest in the adrenergic aspects of IOP
control. Studies of the adrenergic system, and other studies as well, have led to the
hypothesis, for which a great deal of evidence has accumulated, that the adenylate
cyclase receptor complex in the ciliary epithelia plays a central role in the main-
tenance and regulation of IOP. The ability to make measurements of gross outflow
facility relatively easily encouraged a number of investigators to study its role in eye
pressure regulation [1-4]. Interest in the outflow pathways as a regulatory modum
for IOP was further kindled by the finding that increased cyclic AMP levels in
aqueous after adrenergic agents were associated with decreases in IOP and increases
in outflow facility [5-8]. The evidence indicated that even pharmacologic doses of
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those adrenergics increasing outflow facility caused only modest decreases in IOP.
These relatively small changes in IOP modulated by changes in outflow facility did
not approach the larger fluctuations that are encountered with endogenous changes
in IOP such as circadian variation. Furthermore, inaccuracies in the manometric
techniques for measurements of outflow shifted emphasis to inflow as an equally, if
not more important, determinant of steady-state levels of IOP. The diurnal varia-
tion in IOP is most likely the result of changes in net aqueous humor inflow, changes
that more easily account for the magnitude of the fluctuations in pressure. These
more prominent changes in IOP have prompted a search for a pathway for both en-
dogenous and exogenous factors that could be mediated by modulation of aqueous
humor inflow.
HISTORICAL BACKGROUND
Sidler-Hugenin was the first to report a diurnal rhythm in IOP by tactile measure-
ments of eye pressure in 1899 [9]. In 1904 Maslenikow confirmed these findings us-
ing applanation tonometry [10]. Twenty years later, Thiel [11] reported an early
morning peak in diurnal curve. In 1951 Langley and Swanljung identified a number
of patterns of diurnal variation [12]. Later, Drance [13], DeVenecia and Davis [14],
and Katavisto [15] reported on the characteristics of diurnal variations in both nor-
mal and glaucomatous populations.
The physiologic and biochemical bases for these daily swings in IOP have been
elusive. Ericson [16] reported that variations in aqueous inflow were responsible for
the changes in IOP and found that aqueous production decreased at night, cor-
responding to the decrease in IOP usually seen at this time. Schmerl et al. [17] postu-
lated that day-night cycles may lead to the production of neurohumoral factors
which circulate to the eye and regulate IOP. They isolated from the cerebrospinal
fluid of rabbits two compounds, hyperpiesin and myopiesin, which respectively
caused an increase and a decrease in the IOP. Hyperpiesin was produced in rabbits
exposed to light and was later converted to myopiesin during darkness.
The large swings in IOP related to diurnal variation implies the existence of cen-
tral regulation of aqueous humor formation. This concept would require a locus for
regulation, neural and/or humoral mediators, and specific receptors on the target
ciliary epithelia. Duke-Elder [18], Elwyn [19], Hess [20], Magitot [21], and Schmerl
and Steinberg [22] have all hypothesized the existence of one or more centers in the
hypothalamus or diencephalon responsible for the regulation of IOP. Gloster and
Greaves [23] and von Sallman and Lowenstein [24] electrically stimulated the
hypothalamus to induce changes in IOP. These changes were small and transient. In
1951 Nagai et al. [25] reported on changes in IOP induced by electrical stimulation
of the hypothalamus. Many, if not all, of these changes could not be disentangled
from simultaneous changes in systemic blood pressure or blood flow. Recently, at-
tempts have been made to relate efferent fibers in the optic nerve to osmotic altera-
tions of IOP, perhaps mediated by the hypothalamus [26,27]. The search for actual
mediators and receptors of aqueous humor formation in the ciliary body seems more
promising. The ciliary processes themselves contain an enzyme receptor complex,
the catalytic component of which is adenylate cyclase, the enzyme responsible for
the formation of cyclic AMP, a second messenger [28-30]. This receptor complex is
ubiquitous in cell membranes of the tissues of many organisms and is responsible for
many regulatory functions. Evidence implicating a central role for adenylate cyclase
in the regulation of aqueous humor formation is rapidly increasing. Stimulation of
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this enzyme and subsequent increases in intracellular cyclic AMP produced by sev-
eral endogenous or exogenous factors decrease net aqueous humor flow and lower
IOP [29,31-33]. The following studies were conducted in order to investigate the
role of cyclic AMP in the maintenance of eye pressure by changes in net inflow, and
bear on molecular and physiologic mechanisms involved not only in regulation of
IOP but also upon the clinical treatment of elevated pressure in glaucoma.
RECENT STUDIES
The approach to the problem of the molecular mechanisms involved in the control
ofIOP is best done with techniques from several disciplines. In order to link chemi-
cal events occurring at a subcellular level to resultant decreases inIOP, biochemical,
physiological, pharmacological, and anatomical studies were conducted. The iden-
tification and quantification of responses of ciliary adenylate cyclase to chemical
stimuli were studied in vitro. The physiological perturbations in blood flow, aque-
ous flow, outflow resistance, andIOP caused by stimulation of adenylate cyclase by
various agents were studied. Anatomical changes in the ciliary processes after treat-
ment with stimulators of adenylate cyclase are also consistent with the idea that
ciliary cyclic AMP plays a central role in the regulation ofIOP by changes in
aqueous flow.
Several agents known to stimulate cyclic AMP production by different molecular
pathways were used. Cholera toxin is a potent irreversible activator of adenylate
cyclase which binds to cell membrane gangliosides. The gonadotropins (especially
hCG and FSH) are glycoprotein hormones which stimulate cyclase by binding to
specific cell surface receptors. Forskolin, a diterpene derivative of the plant Coleus
forskohlii, penetrates directly to the catalytic unit and stimulates cyclic AMP pro-
duction without interaction with cell surface receptors [34-37]. The classic beta re-
ceptor agonist, isoproterenol, was used in some in vitro studies.
In Vitro Studies
Activation of adenylate cyclase was demonstrated directly by measuring the rate
of conversion of a32Pl ATP to a32P1 cyclic AMP in the particulate fraction of a
broken cell preparation, or indirectly, by measuring cyclic AMP produced by intact
processes [28]. Cholera toxin is a potent irreversible stimulator of adenylate cyclase.
Incubation of intact ciliary processes with cholera toxin significantly increases in-
tracellular cyclic AMP production in concentrations as low as10-10M (Fig. 1). In ad-
FIG. 1. Dose-response relationship betweenz
200 cholera toxin concentration and cyclic AMP pro-
w
*
Extracellular duction by intact ciliary processes (n = 3).
O0 60 Intracellular Ciliary processes were incubated in Hanks' bal-CL T / ) anced salt solution at37° C with the indicated20 concentrations of cholera toxin for five hours.E12
"I Then theophylline was added to a final concen-
Q 80 tration of 10 mM. The processes were incubated
's / an additional 10 minutes, an aliquot of the
medium was removed, 100 percent (w/v) TCA@40- _ . ];/ was added to the tissue suspensions to a finalEs concentration of 6 percent, and the tissue was
00 I I * homogenized. Intracellular and extracellular
0 10.11 10-10 1I-9 10-8107 10-6 cyclic AMP assayed (From Gregory al.
CHOLERA TOXIN CONCENTRATION (M) [33J).
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dition, production of cyclic AMP in intact ciliary processes from human eyes was in-
creased tenfold with either isoproterenol or cholera toxin [29].
Forskolin (Fig. 2) dramatically increased adenylate cyclase activity in rabbit and
human ciliary epithelial preparations. Comparisons of forskolin with other cyclase
stimulators are shown in Fig. 3. Beta blockade in the form of timolol did not alter
this dose-response curve, supporting the concept that forskolin acts directly on the
adenylate cyclase complex independently of cell surface reception. Maximal stimu-
lation of human adenylate cyclase activity from cultured epithelial cells using a for-
skolin concentration, limited by its solubility of 6 x 10-4M, was 57-fold compared
to basal activity.
The effect of isoproterenol stimulation of adenylate cyclase is greatly potentiated
by the presence of forskolin (Table 1). The stimulation of cyclic AMP production in
the presence of forskolin and isoproterenol together is significantly greater than the
sum of the stimulation using either agent alone, indicating that forskolin and
isoproterenol have a synergistic effect on adenylate cyclase stimulation.
The effects of human chorionic gonadotropin (hCG) on adenylate cyclase pro-
duction in crude membrane preparations of ciliary epithelium were investigated.
Significant increases compared to basal activity were easily detected at micromolar
concentrations of hCG (Table 2).
Effect ofAdenylate Cyclase Stimulation on Intraocular Pressure
Intravitreal injections of cholera toxin in concentrations as low as 0.015 jg into
rabbit eyes significantly lowered IOP (Fig. 4). Delivery of 2.1 ,tg of cholera toxin by
close arterial injection via the internal maxillary artery in rabbits also significantly
decreased IOP (Fig. 5).
The effects of both intravitreal and topical forskolin on IOP were investigated.
A B
64
FIG. 3. Stimulation of human
>
32
ciliary adenylate cyclase in vitro.
> 16_ Numbers represent ratios of activity in
C) g-EJISOPROTERENOL the presence of agent to basal activity.
8 _ C NaF Activation by forskolin was sig-J 4FORSKOLIN nificantly greater than isoproterenol
4-j
or NaF. Left panel represents cultured
2 _ // g/m_ fetal human ciliary epithelia. Rightpanel represents freshly excised human
ciliary processes.
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TABLE I
Synergism Between Forskolin and Isoproterenol
Cyclase Activity
(pmol/min/mg protein)
49.7 + 2.3 (3)*
124 + 12 (3)
292 + 18 (3)
616 + 51 (3)
Isoproterenol
Stimulation **
(pmol/min/mg protein)
13.7 + 1.5 (3)
44.7 + 6.7 (3)t
93.7 + 27.4 (3)t
102 + 23 (3)t
* The value is basal cyclase activity. All values
reported are mean + S.E.M.(n).
** Isoproterenol stimulation is adenylate cyclase
activity with 100 pM isoproterenol minus the
activity in the absence of isoproterenol for
each forskolin concentration.
t Isoproterenol stimulation in the presence of
forskolin is greater than the stimulation in the
absence of forskolin (p < 0.05).
An intravitreal dose as low as 0.16 itg significantly reduced IOP three to nine hours
after drug delivery (Fig. 6). Topical forskolin, delivered as a suspension in concen-
trations of 0.1 percent, 0.5 percent, 1.0 percent, and 4.0 percent, dramatically re-
duced rabbit IOP with the duration of action being dose-dependent (Fig. 7). The 1.0
percent topical suspension was also tested in ten monkeys and ten normal human
volunteers. In both cases IOP was significantly reduced for no less than five hours
after a single drop of the suspension (Fig. 8).
Commercial preparations of the gonadotropins hCG and FSH, when delivered in-
travitreally in eyes of normal and oophorectomized rabbits, significantly reduced
TABLE 2
Comparison of hCG Effect on Ciliary Process Adenylate Cyclase
with Effects of Known Activators
Agent
hCG (1 PM)
t-epinephrine (0.1 mM)
sodium fluoride (4 mM)
GTP (10 pM)
Activationa
1.36 ± .08 (5) b
1.82 ± .22 (5) c
7.48 ± .92 (4 )b
1.69 ± .08 (3) d
The values given represent the mean ± S.E.M. (n)
of the ratios of enzyme activity in the presence
of agent to the activity in the absence of agent.
b
p < .005 p < .025 p < .01
~~~pp
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- X S.E.M.) versus time after in-
I I .1 travitreal injection of 0.16 jg (n =
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TI ME (hours) (Modified from Caprioli et al. [45]).
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FIG. 5. Cholera toxin (2.1 itg) was infused via
the right internal maxillary artery of six rabbits
and IOP was recorded by applanation. Mean 4
10 S.E.M. (6) o controls; o treated (Modified from
Gregory et al. [33]).
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FIG. 6. Intraocular pressure (mean ; S.E.M.) versus time after topical delivery of forskolin
suspension 0.1 percent (n = 20), 0.5 percent (n = 20), 1.0 percent (n = 20), and 4.0 percent
(n = 20) in rabbits. Open circles represent significant departures from baseline (p < 0.01).
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z0 of the duration of statisti-
cn 8 /cally significant effect as a
o0 / function of the logarithm of
2 4- toical forskolin concentra-
ti O /tion (percentage suspen-
o IX I sion) in rabbits (5 = 0.97,
0 -1.2 -1.0 -0.8 -0.6 -0.4 -0.2 0 0.2 0.4 0.6 p = 0.0002). X intercept in-
LOG FORSKOLIN DOSE dicates least effective dose.
IOP compared to control eyes in a dose-dependent fashion. The data are represented
as percentage decrease in outflow pressure, assuming an episcleral venous pressure
of 9.0 mm Hg (Fig. 9).
Interestingly, progesterone and quingestanol given in large doses (10-' to 10-4M)
into the vitreous in rabbit eyes did not reduce IOP. This suggests that the hypotony
commonly seen with pregnancy and previously reported to be secondary to elevated
progesterone levels [381 is not caused by progesterone but rather due to high plasma
levels of gonadotropins, particularly hCG (10-7M)[32]. The effect can be reproduced
by systemic injection [32].
Aqueous Flow
Aqueous flow studies were performed after close arterial delivery of cholera toxin
to rabbit eyes [33]. Compared to control eyes, an approximate aqueous flow reduc-
tion of 50 percent was realized in the eyes treated by close arterial infusion of cholera
toxin.
I
MONKEY
I I
HUMAN
2 4
TIME (hours)
FIG. 8. Intraocular pressure (mean 4 S.E.M.)
versus time after administration of 1.0 percent
I forskolin topically in monkeys (n = 10) and
6 8 humans (n = 10). Open circles represent signifi-
cant departures from baseline (p F 0.01).
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75 -\ bit eye reflecting the time
of peak response, usually
about 16 hours. Each point
represents the mean of five
oo o, to eight eyes (Modified fromo-10 10-9 lo-108 i-7 10-6 10-5 Sears and Mead [32]).
The method of intravitreal injections of fluorescein-dextran as described by
Maurice [39] was also used to investigate the effects of aqueous flow by a percent
suspension of topical forskolin. Two weeks prior to the experiment, six rabbits were
injected intravitreally bilaterally with 10 .1 of a 10 percent fluorescein-dextran solu-
tion (MW 40,000). 50 Al of a 1 percent forskolin suspension was applied unilaterally
to four rabbits, and two other rabbits received acetazolamide 25 mg/kg. Three
hours later anterior chamber paracenteses (100 A1) were performed in all animals and
the concentrations of fluorescein determined spectrophotofluorometrically. Com-
parison of treated, control acetazolamide, and untreated eyes revealed an aqueous
flow decrease in the forskolin-treated eyes of 46 + 8 percent, and in the acetazola-
mide-treated eyes of 44 + 10 percent, relative to control normal eyes. This con-
firmed our previous determinations of aqueous flow after topical forskolin, using an
intravenous fluorescein technique, in which a 50 percent decrease in aqueous flow
relative to the control eyes was found [3 1]. Importantly the decrease in outflow pres-
sure and the decrease in net flow were comparable, indicating that the decrease in
IOP can be entirely accounted for by a reduction in aqueous flow. Outflow facility
did not change [33].
Blood Flow
Blood flow measurements were performed using the radioactively labeled micro-
sphere technique previously described by Alm and Bill [40]. After a close arterial in-
fusion of 2.1 gl of cholera toxin into the right internal maxillary artery in rabbits,
blood flow increased and reached a peak of approximately 2.2 times the control eye
at 8 to 13 hours after the infusion [33].
Regional ocular blood flow was also investigated after topical delivery of 50-100
1l of a 1 percent forskolin suspension in rabbits (Fig. 10). Ciliary body blood flow
increased approximately 2.5-fold relative to basal values at approximately one hour
after drug delivery and returned to baseline in approximately four hours. IOP in the
same eyes decreased with lowest IOP levels seen at approximately four hours. Blood
290
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FIG. 10. Forskolin or cholera toxin increases ciliary body blood flow and decreases intraocu-
lar pressure. Results plotted as ratio of treated/untreated, RE/LE; left ordinate, IOP; right or-
dinate, blood flow (Modified from Sears et al. [29]).
flow to the iris, choroid, retina, and optic nerve did not significantly change com-
pared to the contralateral untreated eye. The onset, peak effects, and duration of the
alteration in blood flow and IOP are run on different time courses. Interestingly,
blood flow to structures other than the ciliary body, e.g., choroid, was found un-
altered. The effect of forskolin on blood flow is compared to the effect after cholera
toxin (Fig. 10).
Fine Structural Studies
The apices of the nonpigmented epithelium and the pigmented epithelium of the
ciliary processes face each other as a result of the invagination of the optic vesicle
during embryologic development. These apical surfaces are lined by numerous
microvilli which interdigitate and form a large surface area between these two cell
surfaces. Between these surfaces, a potential space exists, the "ciliary channels," into
which water and metabolites may be secreted. These channels are evident in the
ciliary processes of both normal rabbit and man [41]. In order to study any changes
in fluid flux that may occur as a result of stimulation of adenylate cyclase by some of
the previously mentioned agents, these ciliary channels were investigated with the
aid of electron microscopy. As many as 15 ciliary processes from different regions of
five groups of rabbits were studied for any changes in these ciliary channels. Rabbits
received either intravitreal cholera toxin, topical isoproterenol, topical forskolin,
acetazolamide, topical talc, or no treatment as a control. Those eyes treated with
cholera toxin, isoproterenol, or forskolin, all activators of adenylate cyclase, showed
progressive enlargement of the ciliary channels, with the most dramatic effects evi-
dent with cholera toxin and forskolin (Fig. 1 IA,B,C,D), at a time preceding any
change in IOP. The untreated eyes and the eyes of acetazolamide- or talc-treated
animals revealed ciliary channels ordinary in appearance (Fig. 1 IE,F). These find-
ings indicate a movement of fluid into the expandable apical space between the non-
pigmented and pigmented epithelial cells. The gap, desmosomal and tight junctions
were all intact.
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FIG. 11. Ultrathin sections through anterior ciliary processes (A,C,E) and iridial processes
(B,D,F) one hour after instillation of talc suspension in rabbit cul de sac (A,B), one hour after
I percent topical forskolin suspension (C,D), and four hours after intravenous acetazolamide
25 mg/kg (E,F). Arrows indicate normal ciliary channels (A,B), unchanged ciliary channels
after intravenous acetazolamide (E,F), but enlarged ciliary channels after topical forskolin.
Villiform, once interdigitated, cytoplasmic processes can be seen in separated state (*) within
interapical fluid. x 5,500 Note that zonular occludens, desmosomes, and gap junc-
tions are not disturbed (Courtesy K. Kondo).
DISCUSSION
The finding that IOP is significantly reduced by topical application of the beta
blocker, timolol, has caused a major revolution and scramble in ocular pharma-
cology. New investigations have been pursued that have led to the conclusions that
stimulation of the ciliary epithelial adenylate cyclase complex can reduce IOP by
reducing net aqueous inflow [28,29,32,42]. Timolol indeed may lower IOP by a
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mechanism other than beta blockade [28,43,44]. Furthermore, the recognition that
increased adenylate cyclase activity within the secretory ciliary epithelia of the eye
can reduce IOP has led to new therapeutic possibilities [31,45].
The use of adrenergic agonists to reduce IOP dates at least as far back as 1900
when Darier [46] tried subconjunctival injections of adrenalin. Hamburger [47] ap-
plied the drug topically in the treatment of glaucoma patients. It was largely a result
of the work of Goldmann [48] that it was accepted that topical epinephrine lowered
IOP by reducing aqueous humor formation. Weekers et al. [49] were first to show
that isoproterenol lowered IOP. Garner et al. [50] reported that not all the pressure
reduction by epinephrine could be accounted for by a decrease in inflow. Ballin-
tine [51] and Becker et al. [52], using tonography, measured an increase in outflow
facility after topical epinephrine. Studies of denervation supersensitivity and degen-
eration release in the rabbit, where pseudofacility is unimportant, supported the idea
that outflow of aqueous was increased by epinephrine and that the increase was
mediated by an alpha receptor [1,4,53-56].
These and other clinical observations, especially by Grant [57,58], prompted the
description of the reduction in ocular pressure after topical application of the mixed
adrenergic agonist, epinephrine, by phases [59,60]: first, early, an alpha adrenore-
ceptor effect; second, an intermediate phase lasting several hours which is a beta
adrenoreceptor effect; and finally, a long-term effect (universally) of progressive in-
creases in outflow [61]. This long-term effect may be related to increased mucopoly-
saccharide metabolism in outflow channels [59,62] or perhaps to gradual loss of
agonist from its former pigment binding site [63]. This hypothesis did not com-
pletely address cellular mechanisms but did tend to explain many clinical observa-
tions of the effects on IOP after the use of adrenergic agents.
To avoid the pharmacodynamic complexities of in vivo studies, i.e., the small
change induced as a sum of the action of many possible receptor sites or of toxic ef-
fects on ocular cells, laboratory investigations to characterize the interaction be-
tween drug and beta receptor in the ciliary epithelium, the tissue responsible for the
secretion of aqueous humor, have been done. In a well-controlled, in vitro cell-free
system, the drug concentration at the receptor can be determined. It has been pos-
sible to quantify the drug-receptor relationship [28]. Beta adrenergic receptors were
studied in crude particulate preparations of the ciliary processes of rabbit eyes by a
direct ligand-binding assay using 125I-hydroxybenzyl pindolol [64], and by examin-
ing the kinetic and regulator properties of adenylate cyclase linked to the beta ad-
renergic receptors [28].
High-affinity binding sites for 1251-hydroxybenzyl pindolol were found in the same
particulate membrane fractions of homogenized ciliary processes as adenylate cy-
clase activity. Stimulation of adenylate cyclase activity by catecholamines [65] was
completely blocked by several beta adrenergic agonists, but not by phenoxybenza-
mine, an alpha blocker [5,6]. The Kd is comparable to beta adrenergic receptors of
other tissues. Neufeld and Page [66] found a higher Kd, possibly a reflection of a
technique which included nonspecific binding sites. Kact for stimulation of enzyme
activity was of the order expected for a beta adrenergic receptor-linked adenylate
cyclase, and K,s for inhibition of 1-epinephrine stimulation similar to binding con-
stants for these antagonists to beta adrenergic receptors in other systems. Results
similar to those found by Gregory et al. [28] have been obtained in membrane prepa-
rations from sheep eyes [67,68] and in monkey [69], rabbit [64,66], and human
eyes [30,70,71]. The order of potency of agonist activation indicates that ciliary pro-
cesses contain a predominance of beta2 adrenergic receptors [30]. Finally, binding
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constants determined by the direct ligand-binding technique and by the assay for
adenylate cyclase agree. The agreement certainly suggests that the two techniques
measure the interaction between beta adrenergic ligands and the beta receptor of the
ciliary processes [28].
Thus, although inconsistencies have been found in vivo in studies of inflow and of
outflow after administration of adrenergic agonists, it has been established on a
molecular level that stimulation of the beta adrenergic receptor leads to activation of
membrane-bound adenylate cyclase and to an accelerated rate of production of
ciliary intracellular cyclic AMP. The accelerated production of cyclic AMP stimu-
lated by nonadrenergic agents is consistently associated with decreased IOP as a con-
sequence of decreased net aqueous inflow [72]. Stimulation of the adenylate cyclase
receptor complex by a few molecules of cholera toxin gives physiologic, chemical,
and anatomic evidence for the pressure-regulating role of the adenylate cyclase re-
ceptor complex in the ciliary epithelial tissue of the eye. Exquisitively low doses of
cholera toxin, 2.4 x 10-1M, delivered either by close arterial injection or by intra-
vitreal injection, lowered IOP dramatically by reducing net aqueous inflow [29,33].
The fall in IOP was neither accounted for by a drop in blood flow (which actually in-
creased) nor by any increases in outflow facility [33].
Observations made with forskolin fit the findings with cholera toxin. Forskolin
significantly reduces IOP in rabbits, monkeys, and man [31]. Topical application of
a suspension of this drug lowers rabbit IOP in a dose-dependent fashion. In rabbits,
a single drop of a 1.0 percent suspension decreases net aqueous inflow by nearly
50 percent while increasing ciliary blood flow 2.5-fold. In vitro, forskolin acts as a
direct (cell surface reception not required) potent stimulator of adenylate cyclase in
both rabbit and human ciliary processes. The effects of forskolin are not blocked by
timolol, as would be expected, and the presence of forskolin significantly enhances
the stimulation of cyclic AMP production achieved by isoproterenol.
Still other agents that stimulate adenylate cyclase activity reduce eye pressure by
reducing net aqueous inflow. These preparations include several commercial com-
pounds of the gonadotropin hormones, especially hCG and FSH [32]. hCG, in vitro,
stimulates rabbit ciliary adenylate cyclase activity in crude membrane preparations
of ciliary epithelia. Thus, the adenylate cyclase receptor complex in the secretory
tissue of the eye, the ciliary epithelia, when activated by a variety of pathways, re-
duces the net rate of aqueous inflow and the level of IOP (Fig. 12).
Diverse stimulators of adenylate cyclase, cholera toxin, gonadotropins, and for-
skolin cause IOP and aqueous flow to fall dramatically. How does the adenylate
cyclase receptor complex in the ciliary epithelia act to reduce aqueous inflow?
Cholera toxin has been known to induce watery diarrhea by stimulating an intestinal
epithelial adenylate cyclase with consequent efflux of sodium and water from the
lumen of the intestine [73]. Cholera toxin increases the production of cerebrospinal
fluid by the choroid plexus and increases endolymph production in the inner ear
[74-76]. In all these instances stimulation of adenylate cyclase activity with acceler-
ated production of cyclic AMP in the epithelial cell causes the movement of water
from the basal to the apical portion of the cell and thence into the lumina. The cell
polarity of the ciliary epithelia is reversed because the optic vesicle invaginates dur-
ing development of the eye. The polarity of the cell can explain differences in direc-
tional movement of fluid produced by the epithelia of these different organs. The
polarity of the nonpigmented epithelium (apex toward the pigmented epithelium and
the blood) suggests that the fluid results from absorption across the basolateral or
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FIG. 12. When mediators act ADENYLATE CYCLASE MEDIATED CHANGES IN AQUEOUS FORMATION
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In the ciliary process the beta receptor may be a beta2 receptor rather than both beta, and beta2.
Whether these receptors are distributed evenly or differently across the epithelia and vasculature is not
known at this time.
Beside beta receptors, there are alpha receptors in this scheme. There may be a class of alpha (a) recep-
tors that are linked to inhibit adenyl cyclase. These have not yet been demonstrated for ocular tissue.
There may occur other alpha (a) receptors, alpha1, that are post-synaptic, and not linked to adenylate
cyclase. These may influence the ciliary process through calcium as a second messenger to produce either
vascular or, less likely, epithelial (secretory) effects. These have been demonstrated in the lacrimal and
parotid gland, but not for ciliary process. Finally, there are presynaptic, alpha2 receptors that act in feed-
back, to inhibit norepinephrine synthesis. The effect of these receptors in the ciliary process is unknown
at present but they are known to function elsewhere, as in the retina (Modified from Sears and
Mead [32J).
basal surfaces of the nonpigmented epithelium with secretion from the apices of this
cell layer into the interapical ciliary channels. Evidence from other solute and water-
secreting epithelia such as rabbit ileum and colon, frog stomach and cornea, and
dogfish rectal gland, among others, indicates that apical exit is enhanced by in-
creased production of cyclic AMP [77-79]. For example, an increase in the apical
permeability to chloride and water occurs after an accelerated production of cyclic
AMP in the corneal epithelium. There are no direct measurements of chloride activ-
ity in these cells, so further work is required to establish the hypothesis that intra-
cellular cyclic AMP may regulate solute and water movement via the apex of the
nonpigmented epithelium.
The path for this fluid movement from the apices of the nonpigmented epithelium
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is probably via the intercellular "ciliary channels" into which numerous microvilli
project from the apical parts of pigmented epithelial and nonpigmented epithelial
cells. This area provides an expandable space into which water and metabolites may
be secreted. This channel is prominently seen between the two ciliary epithelial layers
of the iris (iridial processes) in the rabbit and in the anterior part of the ciliary pro-
cesses in both rabbit and man. These channels enlarge after stimulation of adenylate
cyclase [41] but junctions between cells are not disrupted. (Interestingly, enlargement
of these channels was previously described [80] but the author's attention was drawn
to the increase in the smooth endoplasmic reticulum associated with the use of topi-
cal isoproterenol.) The interapical fluid then could find its way from the ciliary
channels into the stroma of the ciliary processes across the pigmented epithelial cell
layer, reducing net inflow of aqueous into the posterior chamber [81]. We have
found, by electron microscopy, after intra-arterial or intravitreal cholera toxin or
hCG or after topical application of forskolin that fluid appears in the space between
the pigmented and nonpigmented ciliary epithelium before the IOP decreases. This
effect is manifested by an increase in the size of the "ciliary channels." Application
of isoproterenol results in similar, though more modest, microanatomical changes.
The source of this fluid is not absolutely certain. It is barely possible that it repre-
sents a transudate across the pigmented epithelium. The polarity of the nonpig-
mented epithelium taken together with two other facts suggests that the fluid results
from absorption across the basal lateral or basal surfaces of the nonpigmented
epithelium with secretion from the apices of the nonpigmented epithelium. Two sup-
porting facts are: (1) evidence from all other solute and water-secreting epithelia
with regard to the function of the apices [82], and (2) the osmotic gradient for water
is toward the ciliary stroma from the posterior chamber under ordinary circum-
stances where the stroma has a protein concentration of 70 percent that of the
plasma [83]. Further increases would not act to reverse this outward direction of
fluid movement, a movement that would be enhanced by cyclase-mediated flow of
solute and water from the apices of the nonpigmented epithelium.
The net solvent flux into the posterior chamber is very likely dependent on the ac-
tive transport of sodium. The system is probably similar to the model of a standing
gradient for osmotic flow related to a relatively tight, moderately high resistance
junction between the nonpigmented epithelia. Studies of rates of entry of nascent
CO2 into the posterior chamber after acetazolamide tend to indicate that solvent and
bicarbonate move together and that the one-way entry of sodium and bicarbonate is
reduced by equimolar amounts. Evidence to couple the activity of the carbonic an-
hydrase system to sodium movement is still being searched for, however. Sodium
could enter the epithelia by the antiporter H+/Na system, perhaps similar to the
renal tubule. The exchange of H+ for Na+ from the stroma resulting in a movement
of Na and HCO3 into the posterior chamber is not unreasonable. Other systems,
such as those for chloride transport or cotransport, have not been well studied in the
ciliary epithelia and remain to speculate about (see schema Fig. 13).
The sum of the forces for the movement of aqueous humor from the stroma into
the posterior chamber and from the posterior chamber into the ciliary channels be-
tween the epithelial cell layers will determine a total "net" flow (Fig. 13). In this view
the adenylate cyclase receptor complex would be regulatory, adjusting net aqueous
inflow. The flow will, in the final analysis, be mediated by enzyme complexes in the
cell membranes. The secretion of a substance against its concentration gradient
across an animal cell plasma frequently involves the coupling of that movement to
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Nonpigmented Ciliary Epithelial Cell
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FIG. 13. A model proposed herein for two-way transport in the nonpigmented ciliary
epithelia that includes a cAMP-mediated increase in apical permeability to chloride in response
to a secretory stimulus and the conventional dogma of a bicarbonate-dependent (perhaps
sodium-coupled) mechanism for movement of water into the posterior chamber.
the electrochemical gradient of sodium created by ATPases. Thus, intracellular ions
from either of the above "opposing" processes may be further regulated by mem-
brane-bound Na-K ATPase activity. Whether it is this enzyme that is a substrate for
phosphorylases activated by cyclic AMP is an issue under study. The demonstration
of cyclic AMP-dependent protein kinase activity within the pigment epithelial cell
layer [84] may represent a first step toward the clarification of the mechanism by
means of which this activity may be influenced. Identification of the phosphorylated
proteins and further studies of phosphorylation in the isolated, dissociated, or cul-
tured non-pigmented epithelium will be important. In this layer the energetics and
enzyme systems for transport are known to be present [85-87].
A combined biochemical, physiological, pharmacological, and anatomical ap-
proach has shed additional light on the molecular mechanisms of IOP regulation.
The role of ciliary adenylate cyclase appears to be central and may represent a "final
common pathway" in eye pressure regulation. Furthermore, these investigations
have drawn attention to an exciting new area of ocular pharmacology. If the reduc-
tion of IOP sufficient to arrest and/or delay optic nerve damage is one goal in glau-
coma treatment, then the stimulation of ciliary cyclic AMP production by a com-
pound such as forskolin represents fertile ground for future research.
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